PDGFRA anticorps (pTyr849)
Aperçu rapide pour PDGFRA anticorps (pTyr849) (ABIN7250785)
Antigène
Voir toutes PDGFRA AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- pTyr849
-
Attributs du produit
- Phosphorylated antibody
-
Purification
- Affinity purification
-
Immunogène
- Synthesized peptide derived from human PDGFR-alpha around the phosphorylation site of Y849.
-
Isotype
- IgG
-
-
-
-
Indications d'application
- WB 1:500-1:2000, IHC 1:100-1:300, ELISA 1:5000
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- PBS with 0.02 % sodium azide, 0.5 % BSA and 50 % glycerol, pH 7.4
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- Store at -20°C. Avoid freeze / thaw cycles.
-
-
- PDGFRA (Platelet Derived Growth Factor Receptor alpha (PDGFRA))
-
Autre désignation
- PDGFRA
-
Sujet
- Receptor that binds both PDGFA and PDGFB and has a tyrosine-protein kinase activity.
-
Poids moléculaire
-
Observed_MW: 140 kDa
Calculated_MW: 123 kDa
-
UniProt
- P16234
-
Pathways
- Signalisation RTK, Fc-epsilon Receptor Signaling Pathway, EGFR Signaling Pathway, Neurotrophin Signaling Pathway, Platelet-derived growth Factor Receptor Signaling
Antigène
-